7d
Zacks Investment Research on MSNInvestors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to KnowNovavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...
Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...
Novavax Inc. closed 64.88% below its 52-week high of $23.86, which the company reached on June 6th.
Novavax (NVAX) reported a large fourth quarter sales decline Thursday — and said it no longer wants to be known simply as a vaccine maker. The COVID-19 vaccine company, based in Maryland ...
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store. Buying stocks after they have lost significant market ...
The Motley Fool on MSN9d
2 Beaten-Down Stocks Near Their 52-Week Lows That Aren't Worth BuyingTilray Brands' results have not been good, nor has the state of the cannabis market. Novavax failed in the COVID-19 space, ...
Bank of New York Mellon Corp lifted its stake in shares of Novavax, Inc. (NASDAQ:NVAX – Free Report) by 0.4% during the ...
Novavax (NVAX) announced that James Young, PhD, is retiring as Chair of the Board and Margaret McGlynn, RPh, has been appointed as his ...
Novavax, Inc. (NASDAQ:NVAX – Get Free Report) has earned an average recommendation of “Hold” from the seven brokerages that are covering the firm, MarketBeat.com reports. One equities research analyst ...
Bullish option flow detected in Novavax (NVAX) with 10,455 calls trading, 2x expected, and implied vol increasing over 6 points to 78.51%. 3/14 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results